Skip to main content

Table 3 Association between local DOAC preference and prescribing of DOACs

From: Trends in anticoagulant prescribing: a review of local policies in English primary care

 

Prescriptions (DDD) (millions)

p value

Cramér’s V

Local DOAC Policy

Recommended DOAC

Other DOACb

Rivaroxaban

Rivaroxaban

1.291

0.843

< 0.005

0.249

Other DOACa

0.738

1.333

Apixaban

Apixaban

0.609

0.339

< 0.005

0.268

Other DOACa

1.068

2.189

Edoxaban

Edoxaban

0.290

0.833

< 0.005

0.377

Other DOACa

0.066

3.016

  1. For policies accessed July – Aug 2019, and prescribing data spanning the same period
  2. aIncludes the two other categories from the set {“Rivaroxaban,” “Apixaban,” “Edoxaban”} besides the one being considered
  3. bIncludes pooled prescriptions of three DOACs from the set {rivaroxaban, apixaban, edoxaban, dabigatran} besides the one being considered
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us